3.225
price down icon15.13%   -0.575
after-market 시간 외 거래: 3.25 0.025 +0.78%
loading
전일 마감가:
$3.80
열려 있는:
$3.72
하루 거래량:
787.39K
Relative Volume:
1.65
시가총액:
$31.85M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.4863
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
-21.72%
1개월 성능:
-45.80%
6개월 성능:
+47.26%
1년 성능:
+29.52%
1일 변동 폭
Value
$3.06
$3.80
1주일 범위
Value
$3.06
$4.2284
52주 변동 폭
Value
$1.50
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
명칭
iBio Inc
Name
전화
302-355-0650
Name
주소
600 Madison Avenue, Suite 1601, New York, NY
Name
직원
54
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
IBIO's Discussions on Twitter

IBIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IBIO
iBio Inc
3.225 31.85M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-28 개시 Chardan Capital Markets Buy
2021-11-29 개시 JMP Securities Mkt Outperform
2021-01-22 개시 Cantor Fitzgerald Overweight
2020-06-26 개시 Alliance Global Partners Buy

iBio Inc 주식(IBIO)의 최신 뉴스

pulisher
Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025
pulisher
Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025
pulisher
Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025
pulisher
Mar 03, 2025

$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq

Mar 03, 2025
pulisher
Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025
pulisher
Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025
pulisher
Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025
pulisher
Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025
pulisher
Feb 20, 2025

iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Feb 19, 2025
pulisher
Feb 19, 2025

iBio Announces Transfer to Nasdaq Capital Market - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Can iBio's Nasdaq Move Transform Its Market Presence? Key Details Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year? - Insider Monkey

Feb 17, 2025
pulisher
Feb 17, 2025

10 Stocks Insiders Are Buying This Year - Insider Monkey

Feb 17, 2025
pulisher
Feb 12, 2025

Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges - TipRanks

Feb 12, 2025
pulisher
Feb 11, 2025

iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Feb 11, 2025
pulisher
Feb 11, 2025

SEC Form 424B3 filed by iBio Inc. - Quantisnow

Feb 11, 2025
pulisher
Feb 10, 2025

iBio Inc. stock falls Monday, underperforms market - MarketWatch

Feb 10, 2025
pulisher
Feb 10, 2025

iBio Inc. (IBIO) reports earnings - Quartz

Feb 10, 2025
pulisher
Feb 10, 2025

iBio, Inc. Reports Second Quarter Fiscal 2025 Financial Results and Corporate Updates on Advancements in Cardiometabolic Therapeutics - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

iBio Reports Fiscal Second Quarter 2025 Financial Results - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

IBIO's Strategic Pivot: AI-Powered Antibody Discovery Shows Promise Despite Q2 Losses - StockTitan

Feb 10, 2025
pulisher
Feb 07, 2025

A Tale of Resilience: iBio Inc Amid Stock Market Turbulence - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

iBio (IBIO) Projected to Post Quarterly Earnings on Friday - Defense World

Feb 07, 2025
pulisher
Feb 04, 2025

iBio (NYSE:IBIO) Trading Up 4% – Time to Buy? - Defense World

Feb 04, 2025
pulisher
Feb 04, 2025

iBio (NYSEMKT:IBIO) Trading Up 1.3% – Still a Buy? - Defense World

Feb 04, 2025

iBio Inc (IBIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):